Biden’s COVID Death Sentence
The “science,” which we’re supposed to “follow,” informs that perhaps 85 percent of COVID-19 victims could have been saved if a proper treatment protocol had been officially established. Early intervention is part of this, as it has long been understood that once a coronavirus patient exhibits advanced symptoms and must be hospitalized and ventilated, survivability greatly diminishes.
Enter drugs such as hydroxychloroquine and ivermectin, which have shown promise in mitigating SARS-CoV-2. Then there’s a newer option: the monoclonal antibody therapy REGEN-COV, which the Food and Drug Administration has authorized for use as a “post-exposure prophylaxis (prevention) for COVID-19 in adults and pediatric individuals … who are at high risk for progression to severe COVID-19, including hospitalization or death,” as the agency puts it. Apparently a game-changer, the drug “has been shown to reduce hospitalization rates by 70 percent for high-risk COVID-19 patients treated within 10 days,” as even an August 26 Week article reprinted by liberal Yahoo! News concedes.
In light of this, what do you think the federal government’s REGEN-COV policy might be?
JBS Member or ShopJBS.org Customer?
Sign in with your ShopJBS.org account username and password or use that login to subscribe.
Subscribe Now
- 24 Issues Per Year
- Digital Edition Access
- Exclusive Subscriber Content
- Audio provided for all articles
- Unlimited access to past issues
- Cancel anytime.
- Renews automatically
Subscribe Now
- 24 Issues Per Year
- Print edition delivery (USA)
*Available Outside USA - Digital Edition Access
- Exclusive Subscriber Content
- Audio provided for all articles
- Unlimited access to past issues
- Cancel anytime.
- Renews automatically